Ecubectedin

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameEcubectedin
Drug Alias NamePM-14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA synthesis inhibitors
TargetsRibonucleic Acid
Therapy Area/IndicationsSolid tumoursSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFranceSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A